Outcomes of perioperative vasopressor use for hemodynamic management of patients undergoing free flap surgery: A systematic review and meta-analysis

Head Neck. 2023 Mar;45(3):721-732. doi: 10.1002/hed.27289. Epub 2023 Jan 8.

Abstract

This systematic review and meta-analysis investigates the objective evidence regarding outcomes in head and neck free flap surgeries using vasoactive agents in the perioperative period. A search was performed in PubMed, Cochrane, Web of Science, and Scopus databases. Inclusion criteria were clinical studies in which vasopressors were used in head and neck free flap surgery during the intraoperative and perioperative period. Eighteen studies (n = 5397) were included in the qualitative analysis and nine (n = 4381) in the meta-analysis. There was no difference in flap failure outcomes with perioperative vasopressor use in head and neck free flap surgery (n = 4015, OR = 0.93, 95% CI [0.60, 1.44]). When patients received vasopressors perioperatively, there was an associated decrease in flap-specific complications (n = 3881, OR = 0.69, 95% CI [0.55, 0.87]). Intraoperative vasopressor use does not negatively impact free tissue transfer outcomes in head and neck surgery and may reduce overall free flap complications.

Keywords: free flap; free tissue transfer; head and neck; vasoactive; vasopressor.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Free Tissue Flaps*
  • Head and Neck Neoplasms* / drug therapy
  • Hemodynamics
  • Humans
  • Intraoperative Period
  • Plastic Surgery Procedures*
  • Postoperative Complications / etiology
  • Retrospective Studies
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Vasoconstrictor Agents